Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The goal of this study is to provide sufficient therapy during the time a patients' B-cell Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LLy) risk category is being determined. The term "risk" refers to the chance of the ALL or LLy coming back after treatment. Primary Objectives * To provide sufficient therapy to enable testing of newly diagnosed acute lymphoblastic leukemia/lymphoma and mixed phenotype acute leukemia/lymphoma tumor samples to determine eligibility and appropriate risk stratification for SJALL therapeutic studies. * To develop a central database of genomic and clinical findings. Secondary Objectives * To assess event free and overall survival data of patients enrolled on this study.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek od 1 roku do 18 lat
- •Rozpoznana białaczka limfoblastyczna (ALL) z co najmniej 25% zmienionymi komórkami w szpiku kostnym
- •Rozpoznany chłoniak limfoblastyczny (LLy) z mniej niż 25% zmienionymi komórkami w szpiku
- •Rozpoznana zmieszana białaczka ostra (MPAL) niezależnie od udziału szpiku kostnego
- •Brak wcześniejszego leczenia skierowanego na nowotwór (z wyjątkami: do 1 iniekcji do opon mózgowych, 1 dawka vincristyny lub napromienianie w nagłych przypadkach)
✗ Disqualifies
- •Ciąża lub karmienie piersią
- •Wcześniejsze leczenie skierowane na nowotwór (poza wymienionymi wyjątkami)
- •Uczestnictwo w innym badaniu klinicznym
- •Poważne wcześniejsze choroby dziedziczne (np. ataksja-teleangiektazja, niedokrwistość Fanconiego)
- •Brak możliwości lub zgody na uczestnictwo w badaniu
Simplified criteria — AI translation
Trial details
- Minimum age
- 1 Year
- Maximum age
- 18 Years
- Last updated (source)
- July 14, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (5)
Rady Children's Hospital
San Diego, United States
Our Lady of the Lakes Regional Medical Center
Baton Rouge, United States
Novant Health Presbyterian Hemby Children's Hospital
Charlotte, United States
Saint Francis Children's Hospital
Tulsa, United States
St. Jude Children's Research Hospital
Memphis, United States
Trial contact
Seth E. Karol, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/15/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.